Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
ViiV Healthcare
Grant: 213096
National Institute for Allergy and Infectious Diseases
Grant: 1 UM1 AI164561-01
NIAID NIH HHS
Grant: P30 AI050410
NIAID NIH HHS
Grant: UM1 AI164561
Fundació Lluita Contra les Infeccions
MeSH Terms
Keywords